Cargando…

Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients

BACKGROUND: No clear guidelines or available studies exist regarding the effects of intensity-modulated radiotherapy (IMRT) of esophageal cancer (EC) on the cardiovascular system. We therefore analyzed a wide range of cardiac vascular dosimetric parameters and clinical characteristics to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiandong, Lv, Yajuan, Chen, Fangjie, Wang, Xiaotong, Zhang, Li, Zhang, Xiaozhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867929/ https://www.ncbi.nlm.nih.gov/pubmed/33569468 http://dx.doi.org/10.21037/atm-21-184

Ejemplares similares

Effect of intensity modulated radiotherapy on lymphocytes in patients with esophageal squamous cell carcinoma and its clinical significance
por: Tian, Xiufang, et al.
Publicado: (2023)

Impact of radiotherapy on circulating lymphocyte subsets in patients with esophageal cancer
por: Lv, Yajuan, et al.
Publicado: (2020)

Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy
por: Pao, Tzu-Hui, et al.
Publicado: (2020)

Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers
por: Chen, Fangjie, et al.
Publicado: (2017)

Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2015)

Clinical results of intensity-modulated radiotherapy for 250 patients with cervical and upper thoracic esophageal carcinoma
por: Zhang, Jiaqi, et al.
Publicado: (2019)

Breast Size and Dose to Cardiac Substructures in Adjuvant Three-dimensional Conformal Radiotherapy Compared to Tangential Intensity Modulated Radiotherapy
por: Ratosa, Ivica, et al.
Publicado: (2020)

Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma
por: Tu, Lingli, et al.
Publicado: (2013)

Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study
por: Lan, Wang, et al.
Publicado: (2022)

Comparison of involved-field intensity-modulated radiotherapy combined with S-1 vs radiotherapy alone for elderly patients with esophageal cancer
por: Liu, Li-Hua, et al.
Publicado: (2022)

Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome
por: Ishida, Yuichi, et al.
Publicado: (2019)

Elevated serum granulocyte-macrophage colony-stimulating factor levels during radiotherapy predict favorable outcomes in lung and esophageal cancer
por: Deng, Guodong, et al.
Publicado: (2016)

A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: Neutrophil lymphocyte ratio/prealbumin ratio
por: Lv, Yajuan, et al.
Publicado: (2019)

Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma
por: Pao, Tzu-Hui, et al.
Publicado: (2021)

Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
por: Yao, Ji-Jin, et al.
Publicado: (2015)

Feasibility of intensity-modulated and image-guided radiotherapy for locally advanced esophageal cancer
por: Nguyen, Nam P, et al.
Publicado: (2014)

Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
por: Cihoric, Nikola, et al.
Publicado: (2015)

Prognostic value of combined preoperative prognostic nutritional index and neutrophil to lymphocyte ratio in esophageal squamous cell carcinoma
por: Zhang, Jiandong, et al.
Publicado: (2020)

The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma
por: Zhao, Jingjing, et al.
Publicado: (2020)

Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma
por: Xie, Dehuan, et al.
Publicado: (2019)

Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer
por: Tang, Ran, et al.
Publicado: (2023)

Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer
por: Luo, Jing, et al.
Publicado: (2023)

Factors relevant to the prognosis of patients with esophageal cancer who received intensity‐modulated radiotherapy
por: Yin, Hongmei, et al.
Publicado: (2018)

Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer
por: Pao, Tzu-Hui, et al.
Publicado: (2020)

Optimization of Minimum Segment Width Parameter in the Intensity-Modulated Radiotherapy Plan for Esophageal Cancer
por: Hong, Jun, et al.
Publicado: (2021)

Dose Reduction to the Scalp with Hippocampal Sparing Is Achievable with Intensity Modulated Radiotherapy
por: Witek, Matthew, et al.
Publicado: (2014)

Radiotherapy for esophageal carcinoma: dose, response and survival
por: Luo, Yijun, et al.
Publicado: (2017)

The Intensity of Radiotherapy-Elicited Immune Response Is Associated with Esophageal Cancer Clearance
por: Ma, Jin-lu, et al.
Publicado: (2014)

Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer
por: Yuan, Meng, et al.
Publicado: (2023)

Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study
por: Wang, Daquan, et al.
Publicado: (2019)

Outcome of dose-escalated intensity-modulated radiotherapy for limited disease small cell lung cancer
por: Yang, Eunyeong, et al.
Publicado: (2023)

A simple optimization approach for improving target dose homogeneity in intensity-modulated radiotherapy for sinonasal cancer
por: Lu, Jia-Yang, et al.
Publicado: (2015)

Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer
por: Roeder, Falk, et al.
Publicado: (2014)

Predictors of Mastoiditis after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: A Dose-Volume Analysis
por: Yao, Ji-Jin, et al.
Publicado: (2016)

Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score‐matched analysis
por: Li, Chen, et al.
Publicado: (2021)

Survival benefit evaluation of radiotherapy in esophageal cancer patients aged 80 and older
por: Huang, Shan, et al.
Publicado: (2017)

Optimized point dose measurement: An effective tool for QA in intensity-modulated radiotherapy
por: Kumar, Alok, et al.
Publicado: (2007)

Dose-Escalated Intensity-Modulated Radiotherapy for the Management of Locally Advanced Cervical Cancer
por: Shewalkar, Balaji, et al.
Publicado: (2022)

Cardiac Exposure in the Dynamic Conformal Arc Therapy, Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy of Lung Cancer
por: Ming, Xin, et al.
Publicado: (2015)

Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma
por: Aftab, Omer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qai7d6ajfd2ae9dgia0gt5fbu4